{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:25:51Z","timestamp":1777487151633,"version":"3.51.4"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["APQ-408,675\/2018\\u20137"],"award-info":[{"award-number":["APQ-408,675\/2018\\u20137"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["APQ-02"],"award-info":[{"award-number":["APQ-02"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["167\\u201321"],"award-info":[{"award-number":["167\\u201321"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.actatropica.2022.106412","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T11:52:16Z","timestamp":1647431536000},"page":"106412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum"],"prefix":"10.1016","volume":"230","author":[{"given":"Amanda S.","family":"Machado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danniele L.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7882-215X","authenticated-orcid":false,"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via P.","family":"Linhares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamille M.O.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela A.G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel S.","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aratti C.","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-4731","authenticated-orcid":false,"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2022.106412_bib0001","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.meegid.2014.07.028","article-title":"What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity","volume":"28","author":"Abdeladhim","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0002","first-page":"1","article-title":"Vaccination in leishmaniasis: a review article","volume":"26","author":"Abdellahi","year":"2022","journal-title":"Iran Biomed. J."},{"key":"10.1016\/j.actatropica.2022.106412_bib0003","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.vaccine.2011.04.089","article-title":"Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis","volume":"29","author":"Agallou","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0004","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I- and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005311","article-title":"Identification of BALB\/c immune markers correlated with a partial protection to Leishmania infantum after vaccination with a rationally designed multi-epitope cysteine protease a peptide-based nanovaccine","volume":"11","author":"Agallou","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2022.106412_bib0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2018.00465","article-title":"New vaccine formulations containing a modified version of the amastigote 2 antigen and the non-virulent Trypanosoma cruzi CL-14 strain are highly antigenic and protective against Leishmania infantum challenge","volume":"9","author":"Almeida","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0007","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis control team. Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2022.106412_bib0008","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.actatropica.2022.106412_bib0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2051013617741578","article-title":"Liposomal adjuvant development for leishmaniasis vaccines","volume":"5","author":"Askarizadeh","year":"2017","journal-title":"Ther. Adv. Vaccines."},{"key":"10.1016\/j.actatropica.2022.106412_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105560","article-title":"Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel","volume":"155","author":"Bansal","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2022.106412_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110097","article-title":"Lipophosphoglycan-3 recombinant protein vaccine controls hepatic parasitism and prevents tissue damage in mice infected by Leishmania infantum chagasi","volume":"126","author":"Bastos","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.actatropica.2022.106412_bib0014","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbamem.2014.12.005","article-title":"Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate","volume":"1848","author":"Beck","year":"2015","journal-title":"Biochem. Biophys. Acta."},{"key":"10.1016\/j.actatropica.2022.106412_bib0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/imcb.12031","article-title":"Poloxamer 407-chitosan grafted thermoresponsive hydrogels achieve synchronous and sustained release of antigen and adjuvant from single-shot vaccines","volume":"96","author":"Bobbala","year":"2018","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0016","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1590\/S0100-879X2005000700001","article-title":"What about Th1\/Th2 in cutaneous leishmaniasis vaccine discovery?","volume":"38","author":"Campos-Neto","year":"2005","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.actatropica.2022.106412_bib0017","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3389\/fimmu.2018.01690","article-title":"Leishmania infantum virulence factor A2 protein: linear B-cell epitope mapping and identification of three main linear B-cell epitopes in vaccinated and naturally infected dogs","volume":"9","author":"Campos","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0018","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1016\/j.vaccine.2009.07.069","article-title":"The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection","volume":"27","author":"Carcel\u00e9n","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.actatropica.2022.106412_bib0019","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carri\u00f3n","year":"2006","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.actatropica.2022.106412_bib0020","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14656566.2019.1609940","article-title":"Current and emerging medications for the treatment of leishmaniasis","volume":"20","author":"Chakravarty","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.actatropica.2022.106412_bib0021","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2022.106412_bib0022","doi-asserted-by":"crossref","first-page":"e1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2022.106412_bib0023","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.vaccine.2003.11.064","article-title":"Pluronic F127-based systemic vaccine delivery systems","volume":"22","author":"Coeshott","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0024","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1128\/IAI.69.11.6776-6784.2001","article-title":"Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8","volume":"69","author":"Colmenares","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2022.106412_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110014","article-title":"Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis","volume":"9","author":"Costa","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2022.106412_bib0026","doi-asserted-by":"crossref","first-page":"92","DOI":"10.11606\/S1518-8787.2018052000381","article-title":"Human visceral leishmaniasis and relationship with vector and canine control measures","volume":"52","author":"Costa","year":"2018","journal-title":"Rev. Saude Publica."},{"key":"10.1016\/j.actatropica.2022.106412_bib0027","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"323","author":"Dias","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0028","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fcimb.2019.00100","article-title":"Modulation of host-pathogen communication by extracellular vesicles (EVs) of the protozoan parasite Leishmania","volume":"9","author":"Dong","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0029","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.vaccine.2020.11.064","article-title":"Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: a new promising vaccine against visceral leishmaniasis","volume":"39","author":"Emerick","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.actatropica.2022.106412_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5699(99)01549-2","article-title":"Organ-specific immune responses associated with infectious disease","volume":"21","author":"Engwerda","year":"2000","journal-title":"Immunol. Today."},{"key":"10.1016\/j.actatropica.2022.106412_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microb."},{"key":"10.1016\/j.actatropica.2022.106412_bib0032","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fimmu.2017.00278","article-title":"The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design","volume":"8","author":"Fleri","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0033","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00436-020-06971-2","article-title":"Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis","volume":"120","author":"Freitas","year":"2021","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2022.106412_bib0034","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/588387","article-title":"Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis","volume":"197","author":"Ganguly","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106412_bib0035","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106412_bib0036","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0037","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/meth.2001.1261","article-title":"An overview of real-time quantitative PCR: applications to quantify cytokine gene expression","volume":"25","author":"Giulietti","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.actatropica.2022.106412_bib0038","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vaccine.2007.11.057","article-title":"A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs","volume":"26","author":"Giunchetti","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.actatropica.2022.106412_bib0039","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1073\/pnas.0712153105","article-title":"Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model","volume":"105","author":"Gomes","year":"2008","journal-title":"Proc. Nat. Acad. Sci. USA."},{"key":"10.1016\/j.actatropica.2022.106412_bib0040","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1016\/j.vaccine.2007.08.001","article-title":"Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant","volume":"25","author":"Goto","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104733","article-title":"Adjuvanted vaccines driven protection against visceral infection in BALB\/c mice by Leishmania donovani","volume":"151","author":"Goyal","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.actatropica.2022.106412_bib0042","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the new world: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2022.106412_bib0043","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/gb-2007-8-2-r19","article-title":"qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data","volume":"8","author":"Hellemans","year":"2007","journal-title":"Genome Biol"},{"key":"10.1016\/j.actatropica.2022.106412_bib0044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pt.2019.10.005","article-title":"New strategies and biomarkers for the control of visceral leishmaniasis","volume":"36","author":"Ibarra-Meneses","year":"2020","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.actatropica.2022.106412_bib0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.exppara.2015.03.027","article-title":"Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis","volume":"153","author":"Jesus-Pereira","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0046","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.vaccine.2007.03.038","article-title":"Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin","volume":"25","author":"Kang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0047","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7555\/JBR.30.20150125","article-title":"Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB\/c mice","volume":"30","author":"Kaur","year":"2016","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.actatropica.2022.106412_bib0048","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106412_bib0049","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2741\/1452","article-title":"Current vaccine adjuvants: an overview of a diverse class","volume":"9","author":"Kensil","year":"2004","journal-title":"Front. Biosci."},{"key":"10.1016\/j.actatropica.2022.106412_bib0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejpb.2014.11.026","article-title":"Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems","volume":"89","author":"Kojarunchitt","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2022.106412_bib0051","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/vaccines8020289","article-title":"Liposomal formulation of chimeraT, a multiple T-cell epitope-containing recombinant protein, is a candidate vaccine for human visceral leishmaniasis","volume":"8","author":"Lage","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.actatropica.2022.106412_bib0052","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.actatropica.2022.106412_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005600","article-title":"Insights into the sand fly saliva: blood-feeding and immune interactions between sand flies, hosts, and Leishmania","volume":"11","author":"Lestinova","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2022.106412_bib0054","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fcimb.2012.00083","article-title":"The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response","volume":"2","author":"Liu","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2020.107941","article-title":"A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease","volume":"216","author":"Machado","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0056","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-0716-1884-4_24","article-title":"In silico design of recombinant chimera T cell peptide epitope vaccines for visceral leishmaniasis","volume":"2410","author":"Machado","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0057","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-1-0716-1884-4_25","article-title":"Preclinical assessment of the immunogenicity of experimental Leishmania vaccines","volume":"2410","author":"Martins","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0058","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.vaccine.2009.11.075","article-title":"Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively","volume":"28","author":"Meddeb-Garnaoui","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.actatropica.2022.106412_bib0059","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biopha.2018.10.143","article-title":"In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic F127-based polymeric micelle system against Leishmania amazonensis infection","volume":"109","author":"Mendon\u00e7a","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.actatropica.2022.106412_bib0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method","volume":"8","author":"Nielsen","year":"2007","journal-title":"BMC Bioinformatics."},{"key":"10.1016\/j.actatropica.2022.106412_bib0061","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/hv.5.5.7607","article-title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","volume":"5","author":"Okwor","year":"2009","journal-title":"Human Vac"},{"key":"10.1016\/j.actatropica.2022.106412_bib0062","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00436-011-2628-5","article-title":"Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB\/c mice using different doses and routes of inoculation of parasites","volume":"110","author":"Oliveira","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2022.106412_bib0063","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3043","article-title":"A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates","volume":"7","author":"Oliveira","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actatropica.2022.106412_bib0064","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/ijms19010129","article-title":"Small myristoylated protein-3, identified as a potential virulence factor in Leishmania amazonensis, proves to be a protective antigen against visceral leishmaniasis","volume":"19","author":"Oliveira","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actatropica.2022.106412_bib0066","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1080\/14760584.2021.1991795","article-title":"Vaccines against leishmaniasis: using controlled human infection models to accelerate development","volume":"20","author":"Parkash","year":"2021","journal-title":"Expert Rev. Vac."},{"key":"10.1016\/j.actatropica.2022.106412_bib0067","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.2147\/IJN.S103344","article-title":"Pluronic P123\/F127 mixed micelles delivering Sorafenib and its combination with verteporfin in cancer cells","volume":"11","author":"Pellosi","year":"2016","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.actatropica.2022.106412_bib0068","doi-asserted-by":"crossref","first-page":"e12784","DOI":"10.1111\/pim.12784","article-title":"Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis","volume":"42","author":"Pereira","year":"2020","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.actatropica.2022.106412_bib0069","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-065X.2006.00432.x","article-title":"Immune privilege in sites of chronic infection: leishmania and regulatory T cells","volume":"213","author":"Peters","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.actatropica.2022.106412_bib0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.imbio.2017.10.043","article-title":"Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis","volume":"223","author":"Portela","year":"2018","journal-title":"Immunobiology"},{"key":"10.1016\/j.actatropica.2022.106412_bib0071","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0264-410X(02)00189-5","article-title":"Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB\/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation","volume":"20","author":"Rafati","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0072","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-7-3","article-title":"Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis","volume":"7","author":"Ramirez","year":"2014","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.actatropica.2022.106412_bib0073","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","article-title":"Visceral leishmaniasis: an overview of vaccine adjuvants and their applications","volume":"37","author":"Ratnapriya","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0074","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/nar\/gkr834","article-title":"Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species","volume":"40","author":"Raymond","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.actatropica.2022.106412_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/14760584.2016.1105135","article-title":"Leishmania vaccine development: exploiting the host-vector-parasite interface","volume":"15","author":"Reed","year":"2016","journal-title":"Expert Rev. Vac."},{"key":"10.1016\/j.actatropica.2022.106412_bib0076","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/pim.12223","article-title":"Identification of immunodominant Leishmania major antigenic markers of the early C57BL\/6 and BALB\/c mice infection stages","volume":"37","author":"Sassi","year":"2015","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.actatropica.2022.106412_bib0077","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0078","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ijbiomac.2017.07.161","article-title":"Chitosan coated PluronicF127 micelles for effective delivery of amphotericin B in experimental visceral leishmaniasis","volume":"105","author":"Singh","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0079","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/iai.63.9.3559-3566.1995","article-title":"Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis","volume":"63","author":"Soong","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2022.106412_bib0080","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0081","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.parint.2018.10.005","article-title":"A Pluronic F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection","volume":"68","author":"Tavares","year":"2019","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.actatropica.2022.106412_bib0082","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1051\/parasite\/2020027","article-title":"A clioquinol-containing Pluronic F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model","volume":"27","author":"Tavares","year":"2020","journal-title":"Parasite"},{"key":"10.1016\/j.actatropica.2022.106412_bib0083","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpb.2012.11.020","article-title":"Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery","volume":"84","author":"Todoroff","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actatropica.2022.106412_bib0084","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00430-019-00640-7","article-title":"A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB\/c mice","volume":"209","author":"Vakili","year":"2020","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.actatropica.2022.106412_bib0085","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1016\/S0264-410X(01)00142-6","article-title":"Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21","volume":"9","author":"Waite","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106412_bib0086","first-page":"22","article-title":"Control of the leishmaniases","year":"2016","journal-title":"World Health Organ Tech. Rep. Ser"},{"key":"10.1016\/j.actatropica.2022.106412_bib0087","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","article-title":"Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections","volume":"9","author":"Zanin","year":"2007","journal-title":"Microbes Infect"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X22001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X22001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:31:56Z","timestamp":1777386716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X22001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":85,"alternative-id":["S0001706X22001103"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2022.106412","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2022.106412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106412"}}